Influenza A+B Virus Antigen Rapid Test Kit (Colloidal Gold)

• INTENDED USE

The Influenza A/B virus Antigen Rapid Test Kit (Fluorescence immunochromatography) is  intended for vitro qualitative detection of the Influenza A/B virus antigen in human nasopharyngeal swab (NPS) and Oropharyngeal swab(OPS). For professional in vitro diagnostic use only.

• CLINICAL SIGNIFICANCE

Influenza, often referred to as "flu", is caused by the influenza virus, a highly contagious viral infection of the respiratory tract that can be spread by coughing or sneezing. Influenza outbreaks occur every fall and winter. Influenza is divided into influenza A virus, influenza B virus and influenza C virus. Influenza A virus has strong variability, followed by influenza B virus, and influenza C virus is relatively stable.

The rapid identification and diagnosis of influenza A and B is of great significance for obtaining effective antiviral therapy. The gold standard for laboratory diagnosis is the virus isolation and culture method, but this method has a long time period, which seriously affects the timely medication and treatment of patients. Compared with the cell culture method, reverse transcription polymerase chain reaction (RT-PCR) has higher sensitivity, but the RT-PCR method has higher cost, requires 4-6 hours of experimental time, and is more professional in experimental operation. Therefore, the field application is limited. The Influenza A/B virus Antigen Rapid Test Kit (Fluorescence Immunochromatography) provides a simple and quick auxiliary differential diagnosis method for influenza A and B using nasopharyngeal or oropharyngeal swab specimens.

• PRODUCT SPECIFICATION

Specimen: Nasopharyngeal swab (NPS) and Oropharyngeal swab(OPS)

Reaction Time: 15 min

Packing Size: 25 Test/Kit

Storage Temperature: 4-30℃

Qualification: CE